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Abstract
Background: Several clinical measures of sensory and motor function are used alongside patient-rated
questionnaires to assess outcomes of carpal tunnel decompression. However there is a lack of evidence regarding
which clinical tests are most responsive to clinically important change over time.
Methods: In a prospective cohort study 63 patients undergoing carpal tunnel decompression were assessed using
standardised clinician-derived and patient reported outcomes before surgery, at 4 and 8 months follow up. Clinical
sensory assessments included: touch threshold with monofilaments (WEST), shape-texture identification (STI™ test),
static two-point discrimination (Mackinnon-Dellon Disk-Criminator) and the locognosia test. Motor assessments
included: grip and tripod pinch strength using a digital grip analyser (MIE), manual muscle testing of abductor
pollicis brevis and opponens pollicis using the Rotterdam Intrinsic Handheld Myometer (RIHM). The Boston Carpal
Tunnel Questionnaire (BCTQ) was used as a patient rated outcome measure.
Results: Relative responsiveness at 4 months was highest for the BCTQ symptom severity scale with moderate to
large effects sizes (ES = -1.43) followed by the BCTQ function scale (ES = -0.71). The WEST and STI™ were the most
responsive sensory tests at 4 months showing moderate effect sizes (WEST ES = 0.55, STI ES = 0.52). Grip and pinch
strength had a relatively higher responsiveness compared to thenar muscle strength but effect sizes for all motor
tests were very small (ES ≤0.10) or negative indicating a decline compared to baseline in some patients.
Conclusions: For clinical assessment of sensibility touch threshold assessed by monofilaments (WEST) and tactile
gnosis measured with the STI™ test are the most responsive tests and are recommended for future studies. The
use of handheld myometry (RIHM) for manual muscle testing, despite more specifically targeting thenar muscles,
was less responsive than grip or tripod pinch testing using the digital grip analyser (MIE). When assessing power
and pinch strength the effect of other concomitant conditions such as degenerative joint disease on strength
needs to be considered.
Background
Carpal tunnel syndrome (CTS) is an entrapment neuro-
pathy of the median nerve at the wrist causing numb-
ness, tingling and pain in the palm, thumb, index and
middle fingers as well as weakness of the thenar mus-
cles. CTS is an important contributor to impaired hand
function, work disability and increased dependence in
adults[1]. It is estimated that one third of patients diag-
nosed with CTS will require surgery to decompress the
carpal tunnel[2]. Surgical intervention has been found to
be effective in reducing disability and improving health-
related quality of life [3,4] and is cost-effective [5] in
patients with moderate to severe pathology. Several sys-
tematic reviews on the effectiveness of surgical [6,7] and
non-surgical treatments [8,9] have been published. How-
ever, the wide range of outcomes assessed has impeded
the pooling of results for meta-analysis[10] and there is
al a c ko fc o n s e n s u so nw h i c h tests should be used in
trials of treatment effectiveness for CTS. In a qualitative
study on what patients consider important criteria for
judging the success of surgery [11] the following out-
comes were identified: symptom resolution, specifically
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ing, improved muscle function, return to work and
resumption of everyday activities. A range of patient-
rated outcome measures and clinically derived assess-
ments are available to measure these domains and a
combination of both patient-reported and clinician-
derived outcomes is advocated ensuring that patients’
perspectives on their health status are included in eva-
luations of effectiveness.
The Boston Carpal Tunnel Questionnaire (BCTQ)
[12] is a disease-specific, patient-reported questionnaire
which has extensive research underpinning its validity,
reliability and responsiveness in patients with CTS [13].
It has been widely used as a primary outcome measure
in trials and has shown superior responsiveness com-
pared to other region-specific or generic patient-rated
questionnaires such as the DASH or SF-36 [14,15].
However the answer to the question of which physical
measures of hand sensibility and hand strength should
be used in clinical trials in CTS has continued to elude
us. As a result clinicians and researchers continue to
use different tests to assess sensibility and strength mak-
ing comparison across centres difficult. Moreover the
use of multiple tests of sensory and motor function may
unnecessarily duplicate information whilst increasing
assessor burden.
Several tests of sensibility are available and studies on
their validity, reliability and responsiveness in peripheral
nerve injuries have been published [16], but little is
known about their relative responsiveness in patients
undergoing surgery for carpal tunnel syndrome. A sys-
tematic review of the outcomes assessed in 28 rando-
mised controlled trials comparing open with endoscopic
carpal tunnel release [17] found that sensory function
was assessed by a range of clinical performance tests in
15/28 studies and motor function in 24/28 studies. A
subsequent statistical review of those trials assessing
grip, pinch and manual muscle strength [18] found that
aw i d er a n g eo fs t r e n g t ht e s t sw e r eu s e d .A l t h o u g hg r i p
strength assessed by hydraulic dynamometry was most
commonly used it was not the most responsive indicator
of change. This may in part be explained by the fact that
power grip does not specifically target the thenar mus-
cles and may also be affected in the short-term by pain
and tenderness over the surgical scar. The authors
recommended further investigation into different meth-
ods of assessing power, pinch grip and manual muscle
testing including the use of handheld myometry for
manual muscle testing of thenar muscles and over a
longer follow-up period than 12 weeks. This prospective
observational study was designed to investigate the rela-
tive responsiveness of several clinically derived tests of
motor and sensory function in patients undergoing car-
pal tunnel decompression over a follow-up period of 8
months after surgery. The tests which best capture
change can then be recommended as part of a core set
of outcome measures for use in clinical practice and
future trials.
Methods
We conducted a longitudinal cohort study using
repeated measures of clinician derived and patient-
reported outcomes. The study received full approval
from the Norfolk Research Ethics Committee (Ref 09/
H0310/2) and the local NHS Trust Research and Devel-
opment Department. All participants gave written
informed consent.
Patients were recruited from a single centre, the Nor-
folk and Norwich University Hospital covering the oper-
ating lists of four consultant orthopaedic or plastic
surgeons. Patients were identified from the Day Proce-
dure Unit’s surgical waiting lists, which is made up of
patients who have been referred either directly by their
general practitioner or seen by an orthopaedic or plastic
surgeon and listed for carpalt u n n e ld e c o m p r e s s i o n .
CTS was diagnosed by signs, symptoms and clinical his-
tory and nerve conduction studies (NCS) were only car-
ried out in those patients in whom the diagnosis by
clinical presentation was uncertain. As not all patients
undergo NCS and due to ethical constraints of accessing
such data it was not possible to classify CTS severity.
Administrative staff at the Day Procedure Unit were
asked to mail participant information sheets, consent
forms and pre-assessment questionnaires with a self
addressed envelope to all patients listed for carpal tun-
nel surgery between April 2009 and April 2010. Patients
were given 1 week in which to decide whether to take
part and return their signed consent form and screening
questionnaire by mail. Inclusion criteria were a con-
firmed diagnosis of CTS through a clear clinical history
with or without neurophysiological examination, listed
for surgical decompression with a date of surgery at
least 2 weeks away, aged 18 or over and able to give
fully informed consent.
Patients returning a signed consent form were invited
to attend for their presurgical assessment at the Clinical
Trials Unit at the University of East Anglia.
Clinician derived measures of sensory and motor func-
tion which have been standardised on populations with
peripheral nerve trauma and/or compression were used.
Clinical assessments were carried out by two qualified
occupational therapists specialising in hand therapy and
experienced in their use. A standardised protocol was
followed for each test. The order of testing was rando-
mised to control for possible order effects. Four sensory
function tests were selected based on a review of evi-
dence regarding their validity and reliability in periph-
eral nerve injuries (Jerosch-Herold 2003).
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Page 2 of 101) Touch threshold was measured using the Weinstein
Enhanced Sensory Test (WEST) (Bioinstruments, Con-
necticut, USA) which has been demonstrated to have
high validity and excellent inter-and intra-tester reliabil-
ity [19]. The WEST monofilaments have improved tip
geometry reducing slippage [20]and are supplied with
guaranteed calibration. An ascending method of thresh-
o l dt e s t i n gw a su s e ds t a r t i n g with the lightest filament
and randomly interspersing 3 stimuli with 2 ‘shams’.
Detection of at least 1 out of 3 stimuli was used to
determine the lowest threshold and recorded on an
ordinal scale as follows: 0.07 gm = 4: 0.2 gm = 3: 2.0
gm = 2; 4.0 gm = 1; 200 gm = 0; The tip of the thumb
and index finger were tested and a mean score
calculated.
2) Static two-point discrimination (2PD) was mea-
sured using the Dellon-Mackinnon Disk-Criminator
™(AliMed, MA, USA) following Moberg’s protocol [21].
Starting with a calliper distance of 5 mm a few random
applications of 1 or 2 points was used to determine if
patients could discriminate correctly then increasing or
decreasing the distance depending on responses. The
final threshold was determined as the smallest distance
at which at least 7 out of 10 applications were correctly
identified. The tip of the thumb and index finger were
tested and a mean value calculated.
3) Locognosia was assessed using a standardised area
localisation test [22]. Using a hand map in which the
fingertips are divided into four quadrants and consecu-
tively numbered, patients were asked to identify the
exact quadrant in which they felt a stimulus using the
heaviest monofilament on the WEST (200 gms). Each
zone is stimulated twice in a pre-randomised order and
1 point is given for each correctly identified digit and
quadrant, respectively. Only the median nerve inner-
vated area was tested with a maximum possible score of
56 points.
4) Tactile gnosis was assessed using the Shape Texture
Identification (STI™) Test (Ossur, Sweden) according to
a standardised protocol [23]. Using three shapes and
three textures of decreasing size fixed onto disks,
patients are required to use their index fingertip to cor-
rectly identify each shape and texture. A maximum of 6
points can be scored.
The choice of motor tests was based on a systematic
review of clinical trials and statistical review of respon-
siveness previously undertaken [18].
Functional grip and tip pinch strength were assessed
using the MIE digital grip analyser (MIE Medical
Research Ltd, Leeds, UK). This instrument has light-
weight padded handles attached to a strain gauge ten-
sion dynamometer and was chosen for its ability to
register even very weak grip and greater handle comfort
compared to the hydraulic dynamometer which requires
a visual reading from a scale and has been shown to
have flooring effects [24]. A standardised protocol was
used to measure power grip and tip pinch using the
positioning recommended by the Clinical Assessment
Recommendations of the American Society of and
Therapists [25]. The mean of three trials was recorded.
Individual muscle testing of Opponens Pollicis (OP)
and Abductor Pollicis Brevis (APB) was performed using
the Rotterdam Intrinsic Handheld Myometer (RIHM)
(Erasmus Medical Centre, Rotterdam) The RIHM is a
digital handheld myometer which allows individual mus-
cle strength to be measured and quantified in Newtons
of force. It has not been used with CTS patients, how-
ever it is validated for use in peripheral nerve injuries
[26,27] and has been shown to have excellent test-retest
reliability. It is much more sensitive to small changes
compared to the ordinal Oxford scale for manual mus-
cle testing but a grade 3 or more must be achieved on
the Oxford scale in order to complete the RIHM testing.
A standardised protocol was followed and the average of
three trials was recorded. Prior to testing motor func-
tion all patients were asked whether they had pain on
gripping or pinching at the base of their thumb and this
was recorded.
Data on clinical presentation of CTS were collected
using the clinical history questionnaire developed by
Bland [28] which was incorporated into a screening
questionnaire sent as part of the initial invitation. It has
been shown to have an overall sensitivity of 79% when
compared to nerve conduction results as gold standard
[28].
Patient rated symptom severity and functional status
were assessed using the disease-specific Boston Carpal
Tunnel Questionnaire [29]. It is made up of two scales -
the symptom severity scale (SSS) which contains 11
questions and the functional status scale (FSS) which
has 8 questions. Patients were asked to rate the severity
or difficulty from 1 to 5 and an average total score cal-
culated for each subscale where a higher score indicates
worse symptoms and function, respectively. Patients
r e c e i v e dt h eq u e s t i o n n a i r eb ym a i la n dw e r ea s k e dt o
bring it completed to their baseline assessment.
The same battery of tests was used for all follow-up
assessments. Additionally we used a subjective global
rating scale at the 4 and 8 month follow-up assessments.
Participants were asked, prior to completing their objec-
tive assessments, whether they felt that overall their
hand had improved, stayed the same or deteriorated
since surgery. This was used as an external criterion to
determine clinically important change and test for dif-
ferences between those improved and those who
remained the same or got worse. Such anchor-based
approaches are considered important in externally vali-
dating whether the change observed in outcome
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and is of clinical importance [30].
Statistical methods
Descriptive statistics were used to summarise the char-
acteristics of the cohort and the outcomes at baseline, 4
and 8 months. Responsiveness for each outcome vari-
able over time was quantified using the Effect Size
(mean change divided by the baseline standard devia-
tion) and the Standardised Response Mean (mean
change divided by the standard deviation of change)
(SRM). An effect size of <0.3 is considered small, 0.5 is
moderate and >0.8 large [31].
The change in outcome was also considered by Patient
Global Assessment. A two-sample t-test (with 95% con-
fidence interval) was used to test for a mean difference
in change between those reporting an improvement and
those not.
Results
Between April 2009 and April 2010 a total of 267
patients listed for carpal tunnel decompression were
invited to participate in the study. 81 (30.3%) patients
consented of whom 67 attended a baseline assessment.
Four patients subsequently postponed or cancelled their
surgery thus becoming ineligible for the study and these
were excluded from the baseline analysis (see Figure 1).
Table 1 summarises the sociodemographic and clinical
characteristics of the 63 patients assessed at baseline.
There was an almost equal distribution of gender and
the mean age of the sample was 60.4 years. 38 patients
had idiopathic CTS.
S u m m a r ys t a t i s t i c sf o rt h ec l i n i c a ls e n s o r ya n dm o t o r
tests and self-reported symptom and function scale at
baseline, 4 months and 8 months follow-up are pre-
sented in table 2. The proportion of patients scoring
normal and below normal results for each of the 4 sen-
sory tests and at each timepoint is presented in Figure
2. Two-point discrimination was normal in more than
70% of patients pre-operatively whereas touch threshold,
locognosia and tactile gnosis were the tests showing the
largest proportion of patients with pre-operative sensory
deficits. By 8 months tactile gnosis was still below nor-
mal for 30% of patients.
Table 3 presents the relative responsiveness of the
four sensory and four motor tests and the symptom and
function subscale of the BCTQ. ES and SRM for 2PD
were negative as a reduction in threshold, measured in
mm, indicates an improvement. For abduction and
opposition measured by RIHM a negative ES or SRM
indicates a decline in strength.
Moderate effect sizes were observed for the WEST
and STI tests at 4 months and 8. All four motor tests
had either small or negative effect sizes. The BCTQ SSS
was the most responsive test with a large ES, followed
by the FSS over a 4 months follow-up.
Table 4 presents the change from baseline to 4 and 8
months for those patients who had self-reported an
improvement and those who had remained the same or
become worse. Ten patients considered that they had
either not improved or got worse by 4 months and two
patients went on to have revision surgery. There were
statistically significant differences between the improved
and not improved groups at 4 months in the BCTQ SSS
and FSS. A highly significant difference was also seen
between these groups in grip at 4 months with the not
improved group showing a mean decline in strength of
-17.33 Newtons from baseline. No significant differences
were observed between improved and not improved for
any outcomes by 8 months.
Discussion
This study is the first to present a comparison of the
relative responsiveness of several clinical sensory and
motor tests in a cohort of patients who have undergone
open carpal tunnel decompression and over an 8 month
follow-up period.
Responsiveness statistics such as ES or SRM give a
standardised score which is unit free and allows com-
parison between different measurement scales. ES and
SRM can be interpreted using Cohen’s criteria [31]
whereby the larger the effect size the greater the change
or response to treatment. However caution is needed in
interpreting these values. Both ES and SRM use a stan-
dard deviation as denominator hence large variance in a
study sample leads to a larger measure of dispersion
(standard deviation) and can therefore result in small
effect sizes even when the change is clinically important.
Both ES and SRM are also dependent on the interven-
tion and how much change is expected in a patient’s
health-status, responsiveness statistics are context-speci-
fic and there are no agreed criteria for what is a respon-
sive measure [32]. Therefore comparing the
responsiveness between tests in the same group of
patients all undergoing surgery for CTS is more appro-
priate than between studies, as it is based on the inter-
pretation of the relative magnitude of ES or SRM rather
than the absolute values.
Of the four clinical sensory tests the most responsive
tests at 4 months from baseline were touch threshold
assessed by WEST (ES = 0.55, SRM = 0.59) and tactile
gnosis assessed with the STI test (ES = 0.53, SRM =
0.66) which showed moderate effect sizes. This was fol-
lowed by locognosia (ES = 0.29, SRM = 0.37) and 2PD
(ES = -0.22, SRM = -0.57) with small effect sizes. The
responsiveness statistics increased slightly by 8 months
indicating that sensibility continued to improve between
4 and 8 months but also remained abnormal for touch
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Page 4 of 10threshold, locognosia and tactile gnosis for more than
30% of patients. Notable is that 2PD was normal (<5
mm) in 46 of 63 patients at baseline (mean at baseline =
4.3 mm) increasing only by 1 patient at 4 and 8 months.
A number of authors have reported that 2PD often
remains normal in CTS when other sensibility indices
show abnormal results [33] and that touch threshold is
more responsive than 2PD [34]. The responsiveness for
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participants listed for CTD who 
consented to participate in study 
(n=81) 30.3% response rate. 
Withdrew before baseline n=3 
Surgery outside recruitment 
period or cancelled  (n=7)    
Unable to contact (n=4)   
 
 
Assessed at baseline n=67 
Analysed at baseline n=63 
Available   for  4/12 assessment n=57 
Analysed at 4/12 n= 57 
Subsequently cancelled 
surgery n=4   
Died n=1  
Lost to follow-up n=5    
 
Available for 8/12 assessment n=55  
Analysed at 8/12 n= 55    
Moved out of area n=1* 
Lost to follow-up at 8/12 n=2 
Potentially eligible participants 
listed for CTD between Jan-Dec 
2010 (n=267)  
Figure 1 Flowchart of patients invited, recruited and follow-up. *Returned BCTQ by post but no other measures taken.
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Page 5 of 10Table 1 Baseline Characteristics (N = 63)
Gender Male 31 Relief by Shaking? Yes 44
Female 32 No 19
Age Mean (SD) 60.4 (13.5) Relief by splinting? Yes 14
range 30 to 91
No 11
Side Operated Left 24 No splint given 38
Right 28 Length of symptoms?
0-3 months 1
Both 11 4-6 months 8
7-12 months 9
Previous Operation Yes 4 >12 months 45
No 59
When are symptoms worse? at Night 50
Hand Dominance Left 3 in the morning 33
Right 58 while working 42
Ambidextrous 2 while driving 32
Worse Side Left 22 Previous Stroke 4
Right 26 Diabetic 12
Both 15 On Dialysis 0
Pregnant 0
Worse Finger thumb 40 Arthritis 13
index 52 Previous Trauma 2
middle 60
ring 36
little 16
Table 2 Outcome measures at baseline and follow-up
Outcome variables Baseline
Mean (SD)
[range]
N=6 3
4 Months
Mean (SD)
[range]
N=5 7
8 Months
Mean (SD)
[range]
N=5 5
WEST (0-4, 4 = normal) 2.77 (0.93)
[0 to 4]
3.25 (0.76)
[1 to 4]
3.37 (0.64)
[1.5 to 4]
2-PD (2 to >15 mm) 4.32 (3.00)
[2 to >15]
3.75 (3.07)
[2 to >15]
3.45 (2.82)
[2 to >15]
Locognosia (0 to 56) 45.6 (6.75)
[21 to 55]
47.9 (5.85)
[30 to 56]
48.8 (6.80)
[25 to 56]
STI Test (0 to 6, 6 = normal) 4.32 (1.74)
[0 to 6]
5.18 (1.60)
[0 to 6]
5.31 (1.39)
[0 to 6]
Grip (Newtons of force) 223.0 (92.4)
[38.7 to 452.3]
236.2 (84.2)
[98.3 to 465.3]
235.5 (91.0)
[68 to 460.1]
Pinch (Newtons of force) 59.7 (27.0)
[8.33 to 116]
63.9 (22.5)
[26 to 112.3]
63.3 (23.5)
[21.7 to 129.3]
RIHM Abduction (Newtons) 34.3 (11.7)
[7.3 to 60]
32.5 (13.2)
[0 to 59.3]
30.9 (12.4)
[7.5 to 54.4]
RIHM Opposition (Newtons) 31.6 (12.0)
[9.3 to 61.1]
31.9 (15.3)
[0 to 76]
32.7 (14.2)
[6.7 to 71.3]
BCTQ Symptoms (1 to 5, 1 = no symptoms) 2.82 (0.78) 1.71 (0.59) 1.63 (0.69)
BCTQ Function (1 to 5, 1 no difficulty) 2.19 (0.79) 1.64 (0.59) 1.63 (0.79)
Global rating of Improvement : — 47/57 (82%) 49/56 (88%)
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threshold [14]. In a sample of 22 patients followed for 3
months after surgery a small change was observed (SRM
= -0.30) in touch threshold assessed by monofilaments.
Appleby et al [35] investigated change over 3 months
after surgery in 29 patients. Although they did not
report responsiveness statistics these could be calculated
from the data presented. Touch threshold had a moder-
ate ES (0.67). Our study is the first to include additional
measures of spatial discrimination such as the locogno-
sia test and STI test, which were moderately responsive.
Both tests have been shown to have excellent discrimi-
native validity and responsiveness in peripheral nerve
injuries [22,36,23]. The results of these tests at 8 months
after surgery also highlight that for a proportion of
patients localisation and shape/texture identification
remained impaired.
T h ee f f e c ts i z e sa n ds t a n d a r d i s e dr e s p o n s em e a n sf o r
all four motor tests were either very small, close to zero
or had decreased at 4 months and 8 months. Grip and
pinch strength assessed with the MIE had a relatively
higher responsiveness compared to thumb abduction
and opposition assessed by RIHM. Our study is the first
to report on the responsiveness of the RIHM in patients
with CTS. This handheld digital myometer targets the
thenar muscles, specifically abduction and opposition of
the thumb which are solely reliant on median nerve
innervation. It combines individual manual muscle test-
ing with myometry thus allowing strength to be mea-
sured objectively and on a continuous scale (Newtons of
force) rather than subjectively grading by using the ordi-
nal Oxford scale. We hypothesised that this method of
testing thumb opposition and abduction using the
RIHM would be more responsive than power or pinch
strength, however our results do not support this. Power
and pinch strength measured by the MIE were more
Figure 2 Percentage of patients with normal and abnormal results for each sensory test at baseline, 4 and 8 months after surgery.
WEST = Weinstein Enhanced Sensory Test (abnormal <grade 4), 2PD = two-point discrimination (abnormal ≥5 mm), Loc = locognosia test
(abnormal ≤48 points), STI = Shape Texture Identification test (abnormal ≤ 5 points).
Table 3 Change from Baseline
4 Month
Change
Mean (SD)
N=5 7
ES SRM 8 Month
Change
Mean (SD)
N=5 5
ES SRM
West 0.51 (0.86) 0.55 0.59 0.68 (0.81) 0.73 0.84
2-PD -0.65 (1.13) -
0.22
-
0.57
- 0.99 (1.93) -
0.33
-
0.51
Locognosia 1.95 (5.34) 0.29 0.37 2.78 (6.69) 0.41 0.42
STI Test 0.93 (1.41) 0.53 0.66 1.11 (1.58) 0.64 0.70
Grip 7.55 (52.9) 0.08 0.14 9.13 (61.3) 0.10 0.15
Pinch 2.01 (14.4) 0.07 0.14 1.95 (16.0) 0.07 0.12
RHIM Ab -2.74 (10.9) -
0.23
-
0.25
- 4.38 (8.29) -
0.37
-
0.53
RHIM Opp 0.81 (16.7) 0.07 0.05 - 0.02 (14.1) -
0.00
-
0.00
BCTQ
Symp
-1.12 (0.88) -
1.43
-
1.27
- 1.18 (0.92) -
1.51
-
1.28
BCTQ func -0.56 (0.71) -
0.71
-
0.79
- 0.54 (0.72) -
0.68
-
0.75
ES = effect size (mean of change÷ standard deviation of baseline), SRM =
standardised response mean (mean of change ÷ SD of change)
A negative ES or SRM denotes a decrease in score from baseline. In 2PD (mm
distance) and the BCTQ subscales (scored 1 to 5) a decrease or negative value
indicates an improvement, whereas for all four motor tests a negative value
indicates a decline in strength (Newtons).
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whether both measures are required. It has been argued
before that pinch strength is a more precise measure of
motor impairment in CTS as it relies to a greater extent
on the median nerve innervated thenar muscles, whereas
in power grip weakness can be masked by the synergis-
tic action of long flexors [18]. However the ES and SRM
for grip and pinch at 4 months were very similar and by
8m o n t h sm a r g i n a l l yh i g h e rf o rp o w e rg r i pt h a nt i p
pinch. There are several plausible explanations for these
findings. Power grip can decrease in the short term after
surgery due to pillar pain and scar tenderness over the
carpus, recovering by 8 months and even improving due
to compensatory use of long flexors and the increased
use of the hand in functional activities. Another factor is
that other variables such as age, dominance and gender
can account for large variations in strength. The var-
iance in strength for all 4 measures in our study was
large as evidenced in the wide standard deviations and
as these are used as the denominator when calculating
ES or SRM this can result in small responsiveness statis-
tics. A further possibility is that other comorbidities
such as degenerative joint disease, especially carpometa-
carpal joint osteoarthritis can significantly reduce pinch
strength. In our study 17 patients (27%) reported that
they had pain at the base of the thumb on forceful grip-
ping or pinching. Furthermore, a systematic review of
strength tests found that grip and pinch strength values
prior to surgery were often within or close to normative
values and therefore little scope remains for further
improvement after surgery ins o m ep a t i e n t s[ 1 8 ] ,as o
called ceiling effect.
Although the responsiveness of patient-rated outcome
assessed by BCTQ was not the primary focus of this
study, by 4 months the BCTQ SSS showed the largest
effect sizes followed by the BCTQ FSS. These findings
concur with other studies that have reported large ES or
SRMs for the symptom severity scale and moderate to
large ES for the functional status scale at 3 months post
surgery [12,14,15,37-39]. The BCTQ is a disease-specific
outcome measure which addresses typical symptoms
such as pain, tingling, nocturnal waking which are
relieved or improved upon surgical decompression. It is
therefore not surprising that this measure is more
responsive than clinical tests of sensory and motor func-
tion. It is interesting though, that the responsiveness sta-
tistics for the BCTQ subscales did not increase at 8
months suggesting that the large improvement in symp-
tom relief and functional status occurs rapidly within
the first 3-4 months after surgery, whilst tactile
Table 4 Change from Baseline by Patient Global Assessment
Not Improved
Mean (SD)
Improved
Mean (SD)
Difference p-value 95% C.I.
4 Months
West 0.55 (1.23) 0.50 (0.77) 0.05 0.904 -0.55 to 0.65
2-PD* - 0.10 (1.31) - 0.77 (1.07) 0.67 0.158 -0.11 to 1.44
Locognosia 1.30 (7.17) 2.09 (4.95) - 0.79 0.747 -4.55 to 2.98
STI Test 0.20 (2.15) 1.09 (1.18) - 0.89 0.235 -1.85 to 0.08
Grip -17.33 (21.2) 12.96 (56.2) - 30.30 0.007 -66.70 to -6.11
Pinch -5.30 (13.4) 3.56 (14.3) - 8.86 0.082 -18.74 to 1.01
RIHM Ab -2.36 (10.9) -2.79 (11.0) 0.44 0.924 -8.51 to 9.38
RIHM Opp 1.12 (19.2) 0.75 (16.4) 0.37 0.958 -11.94 to 12.68
BCTQ Symp* - 0.51 (0.80) - 1.25 (0.85) 0.74 0.021 0.15 to 1.32
BCTQ func* 0.08 (0.69) - 0.69 (0.65) 0.77 0.007 0.31 to 1.22
8 Months
West 1.07 (1.06) 0.63 (0.76) 0.45 0.318 -0.20 to 1.10
2-PD* -0.50 (2.77) -1.06 (1.81) 0.56 0.619 -1.01 to 2.14
Locognosia -0.33 (8.62) 3.17 (6.41) -3.50 0.375 -0.49 to 3.63
STI Test 1.57 (2.23) 1.04 (1.49) 0.53 0.562 -0.76 to 1.82
Grip 24.14 (84.2) 6.90 (58.0) 17.24 0.617 -32.85 to 67.33
Pinch 2.09 (19.9) 1.93 (15.6) 0.16 0.984 -12.96 to 13.29
RIHM Ab -5.55 (3.88) -4.26 (8.66) -1.29 0.565 -9.22 to 6.64
RIHM Opp 2.16 (23.7) -0.31 (12.8) 2.47 0.811 -9.98 to 14.92
BCTQ Symp* -1.14 (1.43) -1.18 (0.85) 0.04 0.944 -0.71 to 0.79
BCTQ func* -0.08 (0.87) -0.61 (0.68) 0.52 0.170 -0.04 to 1.09
*for these measures a negative mean value indicates an improvement; for all other measures improvement is indicated by a positive mean value and decline by
a negative mean value
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Page 8 of 10sensibility especially spatial discrimination takes much
longer to recover after surgical decompression hence
the increasing effect sizes from 4 to 8 months.
The BCTQ was also the outcome measure which best
differentiated between the group of patients who had
improved and those unchanged or worse. The mean
change at 4 months from baseline in symptom severity
was -1.25 points in the improved group and -0.51 points
in the same/worse group. For the functional status scale
ac h a n g eo f- 0 . 6 9p o i n t sw a so b s e r v e di nt h ei m p r o v e d
group and 0.08 points in the same/worse group. Atroshi
[38] reported smaller values for minimally clinically
important difference (MCID) for symptom severity (0.8
points) and for the function scale (0.5 points) using
patient satisfaction as the cri t e r i o ni np a t i e n t su n d e r -
going surgery. Our findings also supports the notion
that patients underwent ‘clinically important change’ as
a result of surgery. They also provide an external criter-
ion for interpreting the change scores in the clinical
tests and to determine the magnitude of change which
can be deemed clinically important. For example for the
STI test the change from baseline in the improved
group was 1.09 points as opposed to 0.20 in the same or
worse group.
A potential limitation is that we did not exclude
patients with other conditions. Our study sample
included 4 patients who reported having had a previous
stroke, 13 indicated having arthritis and 12 were dia-
betic. These conditions may account for weakness and/
or sensory impairment from other aetiologies and which
may not respond to surgery. However they are also typi-
cal of the wide range of patients undergoing surgery for
CTS and therefore enhance the generalisability of our
results to other surgical cohorts. A further limitation is
that we were not able to objectively verify whether all
patients had a median nerve pathology as not all
patients have nerve conduction tests prior to surgery.
Finally our sample size is relatively small although larger
than other cohorts for which responsiveness of some
clinical measures has been published.
Conclusions
We conducted the first longitudinal cohort study to
examine the relative responsiveness of several clinical
tests of motor and sensory function. Several of the clini-
cal measures of sensibility showed good sensitivity to
change, especially the touch threshold (WEST) and tac-
tile gnosis (STI test). We recommend the use of these
two sensory tests in the assessment of outcome in future
trials of interventions for CTS particularly in patients
with sensory deficits. Exploring the relationship between
changes in clinical sensory function and sensory para-
meters from nerve conduction studies would also war-
rant further investigation.
Clinical tests of motor function included the assess-
ment of power and pinch grip with the MIE digital
myometer and handheld myometry for thenar muscles
showed very small changes with ES of 0.10 and below.
Power grip was marginally more responsive than tip
pinch and more responsive than abductor pollicis brevis
and opponens testing with the RIHM. Despite the fact
that the RIHM targets more specifically the median
nerve innervated thenar muscles its low responsiveness
suggests that it does not offer any benefits over the
more commonly used and widely available power and
pinch strength tests. Our study shows that some
patients have considerable impairments in sensibility
and strength before and after surgery which are not ade-
quately captured by self-report alone and warrant the
additional use of these clinical objective tests. They
should be considered for inclusion as secondary out-
come measures in future trials.
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